Patent ID: 9173880
Filing Date: 2015-11-03
Classification: A61J,A61K,A61P,C07K

Abstract:
1. A stable pharmaceutical formulation comprising: (i) 5 mg/mL to 200 mg/mL of a human antibody that specifically binds to human interleukin-6 receptor (hIL-6R), wherein the antibody comprises a heavy chain variable region having the amino acid sequence of SEQ ID NO:18 and a light chain variable region having the amino acid sequence of SEQ ID NO:26; (ii) histidine at a concentration of from 25 mM to 100 mM; (iii) arginine at a concentration of from 25 mM to 50 mM; (iv) sucrose in an amount of from 3% to 10% w/v; and (v) polysorbate 20 in an amount of from 0.1% to 0.2%, wherein the formulation has a pH of about 5.8, about 6.0, or about 6.2, and at least 90% of the native form of the antibody is recovered after 1 month of storage at 45° C., as determined by size exclusion chromatography.